Pauline Bottemanne

Avenue E. Mounier 73
Brussels, BRU 1200, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Therapeutic potential of retinoic acid-loaded lipid Nanocapsules in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.

Therapeutic potential of retinoic acid-loaded lipid Nanocapsules in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 24, 2025

Oxysterol-mediated modulation of intestinal inflammation: insights into sex differences and GPR183 signaling.

Oxysterol-mediated modulation of intestinal inflammation: insights into sex differences and GPR183 signaling.

Journal: Cellular and molecular life sciences : CMLS

Published: June 26, 2025

MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line.

MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line.

Journal: Frontiers in cellular neuroscience

Published: November 10, 2023

Influence of a pro-inflammatory stimulus on the miRNA and lipid content of human dental stem cell-derived extracellular vesicles and their impact on microglial activation.

Influence of a pro-inflammatory stimulus on the miRNA and lipid content of human dental stem cell-derived extracellular vesicles and their impact on microglial activation.

Journal: Heliyon

Published: August 14, 2023

Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD2-G.

Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD2-G.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: May 24, 2022

N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.

N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: June 13, 2021

miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions.

miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions.

Journal: eLife

Published: March 13, 2020

Colitis Alters Oxysterol Metabolism and is Affected by 4β-Hydroxycholesterol Administration.

Colitis Alters Oxysterol Metabolism and is Affected by 4β-Hydroxycholesterol Administration.

Journal: Journal of Crohn's & colitis

Published: October 09, 2018

Lysophosphatidylinositols in inflammation and macrophage activation: Altered levels and anti-inflammatory effects.

Lysophosphatidylinositols in inflammation and macrophage activation: Altered levels and anti-inflammatory effects.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: April 26, 2018

Author Correction: Stem cells from human apical papilla decrease neuro‑inflammation and stimulate oligodendrocyte progenitor differentiation via activin‑A secretion.

Author Correction: Stem cells from human apical papilla decrease neuro‑inflammation and stimulate oligodendrocyte progenitor differentiation via activin‑A secretion.

Journal: Cellular and molecular life sciences : CMLS

Published: March 24, 2018

N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities.

N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities.

Journal: Drug discovery today

Published: December 29, 2017

Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate.

Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate.

Journal: Journal of medicinal chemistry

Published: November 08, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026